LIFE CYCLE OF INFLUENZA A – Narrated by: Forest Whitaker
By
admin
This science animation was developed for Zirus, a biopharmaceutical company that was working on the development of a new class of antivirals. This video excerpt, taken from a larger program developed for Zirus, uses the H1N1 influenza-A virus to example the mechanism of action a virus takes to infect a host cell.
A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER
By
Jordan Maire
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments.
THORACIC OUTLET SYNDROME
By
Jordan Maire
Dr. Parth Shah, the Director of Vascular and Endovascular Surgery at the Thoracic Outlet Center at Hartford Healthcare’s Heart and Vascular institute asked XVIVO to create an animation of a surgery he performs to relieve a condition called thoracic outlet syndrome, or TOS.
VOXELOTOR AN INVESTIGATIONAL DRUG FOR SICKLE CELL DISEASE
By
admin
In collaboration with Global Blood Therapeutics, our folks here at XVIVO created this medical animation to illustrate the mechanism of action of a potential drug candidate for the treatment of sickle cell disease (SCD).
IDIOPATHIC PULMONARY FIBROSIS AND THE EFFECTS OF TREATMENT
By
admin
The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.
PALOVAROTENE MOA
By
Jordan Maire
Fibrodysplasia ossificans progressiva, or FOP, is an extremely rare and debilitating disorder, in which bone tissue gradually replaces soft tissue throughout the body, extending the skeleton and “freezing” patients into position.
CUROSURF INTRATRACHEAL SUSPENSION
By
admin
Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, …
FROM MELANOCYTE TO MELANOMA
By
admin
Working with MELA Sciences, we designed this medical animation to help doctors and their patients …
THE ROLE OF SEROTONIN IN CARCINOID SYNDROME
By
admin
In this video, we will discuss tryptophan metabolism as applied to carcinoid syndrome in patients …
APOPTOSIS AND BCL-2
By
admin
ABT-199/GDC-0199 is a small molecule drug in co-development by Abbvie and Genentech for the selective inhibition of BCL-2, a key regulator of cellular apoptosis. BCL-2, part of the larger BCL-2 family, is responsible for the sequestration of pro-apoptotic proteins along the mitochondrial membrane. Displacement of these proteins from BCL-2 in cancerous cells may prime these cells for apoptosis.